Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome
- PMID: 37007968
- PMCID: PMC10050494
- DOI: 10.3389/fgene.2023.1107787
Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome
Abstract
Tenascin-X (TNX) is an extracellular matrix glycoprotein for which a deficiency results in a recessive form of classical-like Ehlers-Danlos syndrome (clEDS), a heritable connective tissue disorder with hyperextensible skin without atrophic scarring, joint hypermobility, and easy bruising. Notably, patients with clEDS also suffer from not only chronic joint pain and chronic myalgia but also neurological abnormalities such as peripheral paresthesia and axonal polyneuropathy with high frequency. By using TNX-deficient (Tnxb -/-) mice, well-known as a model animal of clEDS, we recently showed that Tnxb -/- mice exhibit hypersensitivity to chemical stimuli and the development of mechanical allodynia due to the hypersensitization of myelinated A-fibers and activation of the spinal dorsal horn. Pain also occurs in other types of EDS. First, we review the underlying molecular mechanisms of pain in EDS, especially that in clEDS. In addition, the roles of TNX as a tumor suppressor protein in cancer progression have been reported. Recent in silico large-scale database analyses have shown that TNX is downregulated in various tumor tissues and that high expression of TNX in tumor cells has a good prognosis. We describe what is so far known about TNX as a tumor suppressor protein. Furthermore, some patients with clEDS show delayed wound healing. Tnxb -/- mice also exhibit impairment of epithelial wound healing in corneas. TNX is also involved in liver fibrosis. We address the molecular mechanism for the induction of COL1A1 by the expression of both a peptide derived from the fibrinogen-related domain of TNX and integrin α11.
Keywords: Ehlers-Danlos syndromes; clEDS; fibrosis; pain; tenascin-X; tumor suppressor.
Copyright © 2023 Okuda-Ashitaka and Matsumoto.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Hypersensitivity of myelinated A-fibers via toll-like receptor 5 promotes mechanical allodynia in tenascin-X-deficient mice associated with Ehlers-Danlos syndrome.Sci Rep. 2023 Oct 28;13(1):18490. doi: 10.1038/s41598-023-45638-7. Sci Rep. 2023. PMID: 37898719 Free PMC article.
-
Mechanical allodynia in mice with tenascin-X deficiency associated with Ehlers-Danlos syndrome.Sci Rep. 2020 Apr 16;10(1):6569. doi: 10.1038/s41598-020-63499-2. Sci Rep. 2020. PMID: 32300146 Free PMC article.
-
Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel TNXB Variant.Genes (Basel). 2019 Oct 25;10(11):843. doi: 10.3390/genes10110843. Genes (Basel). 2019. PMID: 31731524 Free PMC article.
-
Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.Horm Res Paediatr. 2018;89(5):352-361. doi: 10.1159/000481911. Epub 2018 May 7. Horm Res Paediatr. 2018. PMID: 29734195 Free PMC article. Review.
-
The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.Front Immunol. 2020 Dec 1;11:609752. doi: 10.3389/fimmu.2020.609752. eCollection 2020. Front Immunol. 2020. PMID: 33335533 Free PMC article. Review.
Cited by
-
Hypersensitivity of myelinated A-fibers via toll-like receptor 5 promotes mechanical allodynia in tenascin-X-deficient mice associated with Ehlers-Danlos syndrome.Sci Rep. 2023 Oct 28;13(1):18490. doi: 10.1038/s41598-023-45638-7. Sci Rep. 2023. PMID: 37898719 Free PMC article.
-
Genetic variants in patients with multiple arterial aneurysms.Langenbecks Arch Surg. 2024 Oct 9;409(1):304. doi: 10.1007/s00423-024-03488-5. Langenbecks Arch Surg. 2024. PMID: 39382597 Free PMC article.
-
The coordinated activities of collagen VI and XII in maintenance of tissue structure, function and repair: evidence for a physical interaction.Front Mol Biosci. 2024 Mar 28;11:1376091. doi: 10.3389/fmolb.2024.1376091. eCollection 2024. Front Mol Biosci. 2024. PMID: 38606288 Free PMC article.
-
Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes.Nat Commun. 2024 Feb 28;15(1):1227. doi: 10.1038/s41467-024-45099-0. Nat Commun. 2024. PMID: 38418480 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous